Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The Phase 1/2 trial dosing is slated for early 2025
Success hinges on market demand and differentiation
It's important to monitor how new initiatives affect both financial and social impact
with over $12M approved capacity within three months and 38% share of Clearco-funded beauty/wellness e‑commerce merchants
Key investors include Sequoia Capital and Samsung Ventures
CHRONOSPHERE PORTER'S FIVE FORCES TEMPLATE RESEARCH B_153 The Phase 1/2 trial dosingGo Beyond the Preview Access the Full Strategic Report Chronosphere faces intense competitive pressure from cloud native observability rivals, evolving buyer demands, and cost sensitive substitutes this snapshot highlights key tensions in pricing, scale, and tech differentiation. Suppliers Bargaining Power Cloud Infrastructure Dominance Chronosphere, a SaaS observability vendor, runs on AWS and Google Cloud, which in 2025 captured ~62% of global cloud
US$ 185.00
US$ 149.95
US$ 155.00
US$ 117.00
US$ 119.99
US$ 200.00
US$ 150.00
US$ 115.00
US$ 175.00
US$ 14.60
US$ 21.00
US$ 175.00
US$ 170.00
US$ 1250.00
